CENTURY ALUMINUM COMPANY (CENX)

US1564311082 - Common Stock

15.42  +0.26 (+1.72%)

After market: 15.42 0 (0%)

Fundamental Rating

3

Taking everything into account, CENX scores 3 out of 10 in our fundamental rating. CENX was compared to 157 industry peers in the Metals & Mining industry. While CENX is still in line with the averages on profitability rating, there are concerns on its financial health. CENX is quite expensive at the moment. It does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

CENX had positive earnings in the past year.
CENX had a positive operating cash flow in the past year.
In the past 5 years CENX always reported negative net income.
CENX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CENX has a Return On Assets of 12.36%. This is amongst the best in the industry. CENX outperforms 92.36% of its industry peers.
CENX has a Return On Equity of 38.02%. This is amongst the best in the industry. CENX outperforms 98.73% of its industry peers.
With a Return On Invested Capital value of 0.35%, CENX perfoms like the industry average, outperforming 45.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 8.91%.
Industry RankSector Rank
ROA 12.36%
ROE 38.02%
ROIC 0.35%
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.78%
ROIC(5y)N/A

1.3 Margins

CENX has a better Profit Margin (10.78%) than 80.89% of its industry peers.
CENX has a Operating Margin (0.29%) which is comparable to the rest of the industry.
With a Gross Margin value of 2.84%, CENX is not doing good in the industry: 64.97% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 0.29%
PM (TTM) 10.78%
GM 2.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
CENX has more shares outstanding than it did 1 year ago.
CENX has more shares outstanding than it did 5 years ago.
CENX has a better debt/assets ratio than last year.

2.2 Solvency

CENX has an Altman-Z score of 0.71. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.71, CENX is not doing good in the industry: 75.16% of the companies in the same industry are doing better.
CENX has a Debt/Equity ratio of 0.76. This is a neutral value indicating CENX is somewhat dependend on debt financing.
CENX has a Debt to Equity ratio of 0.76. This is amonst the worse of the industry: CENX underperforms 84.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACC0.04
WACC8.41%

2.3 Liquidity

CENX has a Current Ratio of 1.67. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.67, CENX is doing worse than 67.52% of the companies in the same industry.
A Quick Ratio of 0.63 indicates that CENX may have some problems paying its short term obligations.
CENX has a worse Quick ratio (0.63) than 85.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 0.63

4

3. Growth

3.1 Past

CENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 184.78%, which is quite impressive.
The Revenue for CENX has decreased by -17.61% in the past year. This is quite bad
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 2.91% on average per year.
EPS 1Y (TTM)184.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.73%
Revenue 1Y (TTM)-17.61%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-11.39%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.34% yearly.
The Revenue is expected to grow by 7.72% on average over the next years.
EPS Next Y-24.32%
EPS Next 2Y73.04%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue Next Year-6.15%
Revenue Next 2Y0.02%
Revenue Next 3Y7.72%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.54, which means the current valuation is very expensive for CENX.
CENX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CENX to the average of the S&P500 Index (24.41), we can say CENX is valued expensively.
Based on the Price/Forward Earnings ratio of 16.61, the valuation of CENX can be described as correct.
CENX's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.59, CENX is valued at the same level.
Industry RankSector Rank
PE 39.54
Fwd PE 16.61

4.2 Price Multiples

CENX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.58

4.3 Compensation for Growth

CENX's earnings are expected to grow with 40.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.04%
EPS Next 3Y40.34%

0

5. Dividend

5.1 Amount

No dividends for CENX!.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (7/26/2024, 7:21:39 PM)

After market: 15.42 0 (0%)

15.42

+0.26 (+1.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.43B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 39.54
Fwd PE 16.61
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.36%
ROE 38.02%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.29%
PM (TTM) 10.78%
GM 2.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 0.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)184.78%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-24.32%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.61%
Revenue growth 3Y10.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y